Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is an oral multi-mineral combination of calcium carbonate, magnesium hydroxide, and zinc gluconate used primarily as a dietary supplement to address nutritional deficiencies and support bone health and overall well-being. Calcium carbonate provides elemental calcium for bone mineralization and also acts as a basic antacid that neutralizes gastric hydrochloric acid. Magnesium hydroxide supplies elemental magnesium, supports neuromuscular function, and also functions as an antacid and mild osmotic laxative, while zinc gluconate provides bioavailable zinc to support immune function, tissue repair, and enzymatic processes. In marketed products, this triple-mineral base is often co-formulated with vitamin D3, but the core mechanism is replacement of deficient minerals rather than specific receptor-targeted pharmacology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium carbonate + magnesium hydroxide + zinc gluconate.